Retrospective analysis of glial tumors in light of the 2016 WHO classification of central nervous system tumours diagnosed at a single center between 2005 and 2016
Journal of Current Hematology & Oncology Research · 18.05.2026 · 4 (2) · 31-39
DOI: 10.51271/jchor-0079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Current Hematology & Oncology Research, online erschienen am 18.05.2026. Verfasst von Nilay Bakoglu Malinowski und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
The 2016 WHO Classification of Tumors of the Central Nervous System introduced a paradigm shift by integrating molecular features with traditional histomorphology. This study aims to retrospectively re-evaluate glial tumor cases from a major tertiary center in light of these evolving classification criteria and provide a baseline for future molecular research.
Methods
A retrospective analysis was conducted on 395 glial tumor cases diagnosed at the Karadeniz Technical University Faculty of Medicine, Department of Pathology, between 2005 and 2016. The cases were re-grouped according to the 2016 WHO criteria. Due to the lack of molecular data available during the archival period, cases were categorized under the “Not Otherwise Specified” (NOS) group to establish a comprehensive database.
Results
Among the 395 cases analyzed, glioblastoma was identified as the most frequent histological subtype (n=235). A male predominance was observed (56.5%), with mean and median ages of 48.21 and 50 years, respectively. The most common anatomical location was the frontal lobe, and Histological Grade IV was the most prevalent grade. Statistical analyses indicated that demographic and distribution data were consistent with global literature.
Conclusion
The findings align with international demographic trends while highlighting the practical challenges of transitioning to molecular-based classifications. While the subsequent 2021 WHO Classification further emphasizes IDH status, "histologically defined" or "NOS" designations remain crucial for regions where molecular testing infrastructure is limited. This study provides a robust archival baseline that facilitates future molecular studies and serves as a reference for glial tumor characterization in resource-constrained settings.
Zitieren
APA
Malinowski, N. B., Çakır, E., & Saygın, İ. (2026). Retrospective analysis of glial tumors in light of the 2016 WHO classification of central nervous system tumours diagnosed at a single center between 2005 and 2016. Journal of Current Hematology & Oncology Research, 4(2), 31-39. https://doi.org/10.51271/jchor-0079
Vancouver
Malinowski NB, Çakır E, Saygın İ. Retrospective analysis of glial tumors in light of the 2016 WHO classification of central nervous system tumours diagnosed at a single center between 2005 and 2016. Journal of Current Hematology & Oncology Research. 2026;4(2):31-39. doi:10.51271/jchor-0079
BibTeX
@article{Malinowski2026,
author = {Malinowski, Nilay Bakoglu and Çakır, Emel and Saygın, İsmail},
title = {Retrospective analysis of glial tumors in light of the 2016 WHO classification of central nervous system tumours diagnosed at a single center between 2005 and 2016},
journal = {Journal of Current Hematology & Oncology Research},
year = {2026},
volume = {4},
number = {2},
pages = {31--39},
doi = {10.51271/jchor-0079}
}
EUVIMED